Company

SPRING PHARMACEUTICAL GROUP, INC. (0000847464)

Standardized SEC financial data for SPRING PHARMACEUTICAL GROUP, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000847464 · Pharmaceutical Preparations.

Gross margin

39.0%

Operating margin

22.8%

Net margin

18.1%

Revenue growth (YoY)

15.0%

Return on equity

10.8%

Free cash flow

$15.7M

Current ratio

15.16×

Ratios for fiscal year 2018, standardized from SEC filings.

Income statement

USD	FY2017	FY2018
Revenue	$56.5M	$64.9M
Cost of revenue	$33.3M	$39.6M
Gross profit	$23.2M	$25.3M
R&D expense	$809K	$492K
SG&A expense	$4.2M	$5.0M
Operating income	$13.2M	$14.8M
EBITDA

Balance sheet

USD	FY2017	FY2018
Cash & equivalents	$10.3M	$25.4M
Inventory	$5.5M	$2.4M
Total current assets	$18.5M	$30.1M
Property, plant & equipment	$14.5M	$16.8M
Total assets	$90.3M	$110.1M
Total current liabilities	$3.0M	$2.0M
Total liabilities

Cash flow

USD	FY2017	FY2018
Operating cash flow	$9.7M	$17.9M
Capital expenditures	$2.9M	$2.2M
Free cash flow	$6.9M	$15.7M
Investing cash flow	-$6.5M	-$4.5M
Dividends paid	$0	$0

Get 0000847464 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000847464/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000847464/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0000847464 filings on SEC EDGAR →